David A. Mankoff
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Biomedical Engineering, RadiologyGoogle:
"David Mankoff"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Muzi M, Peterson LM, Specht JM, et al. (2024) Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials. Research Square |
| Mankoff D, Balogová S, Dunnwald L, et al. (2023) Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[F]Fluoro-17β-Estradiol PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Kazerouni AS, Peterson LM, Jenkins I, et al. (2023) Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer. Breast Cancer Research : Bcr. 25: 138 |
| Linden HM, Mankoff DA. (2023) Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Ulaner GA, Mankoff DA, Clark AS, et al. (2023) Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-F-Fluoro-17β-Fluoroestradiol. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 64: 351-354 |
| O'Brien SR, Edmonds CE, Lanzo SM, et al. (2023) F-Fluoroestradiol: Current Applications and Future Directions. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 43: e220143 |
| Pantel AR, Gitto SB, Makvandi M, et al. (2022) [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a pilot study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Makhlin I, Korhonen KE, Martin ML, et al. (2022) F-FDG PET/CT for the Evaluation of Therapy Response in Hormone Receptor-Positive Bone-Dominant Metastatic Breast Cancer. Radiology. Imaging Cancer. 4: e220032 |
| Mankoff DA, Clark AS, Edmonds CE, et al. (2022) 16α-[F]Fluoro-17β-Estradiol Positron Emission Tomography to Measure Regional Estrogen Receptor Expression in Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201055 |
| Zhou R, Choi H, Cao J, et al. (2022) F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |